Information for the public

Benefits and risks

Benefits and risks

When NICE looked at the evidence, it decided that it showed electrotherapy to be safe enough and to work well enough for use in the NHS to treat grades 1 to 3 haemorrhoids. The 9 studies that NICE looked at involved a total of 2826 patients.

Generally, they showed the following benefits:

  • an improvement in rectal bleeding symptoms 8 weeks after the procedure (no rectal bleeding in 88% of patients and reduced rectal bleeding in 6%), and no rebleeding at 1 year in 95% of patients

  • all symptoms had disappeared and had not come back in 66–82% of patients at 1 year, and there was some improvement in the severity, duration and frequency of symptoms in 10% of patients

  • no new grade 1 or 2 haemorrhoids in 94% of patients for up to 7 years

  • treatment success in 88% of patients after 8 months and an average of 6.5 treatments

  • 93% of patients back to work after 2 days, 5% back to work after 2–6 days, and 2% at home for up to 2 weeks because of pain and discomfort

  • 84% of patients fully satisfied with the treatment, 12% were moderately satisfied, and 4% were not satisfied.

The studies showed that the risks of electrotherapy for haemorrhoids included:

  • severe pain in 2% of patients, moderate pain in 68% and mild pain in 30% during the treatment, and pain that resulted in the treatment being stopped in 20% of patients

  • pain lasting more than 1 day after treatment in 16% of patients and, 7 days after treatment, moderate pain in 7% and mild pain in 15% with low power electrotherapy and in 15% with high power electrotherapy

  • rectal bleeding in 12% of patients 1–48 hours after the procedure and in 16% of patients 48 hours after the procedure

  • rectal ulceration in 1 patient

  • retention of urine in 8% of patients treated by high power electrotherapy, 6% of whom needed a catheter once and 2% of whom needed a urinary catheter 2–3 times

  • fainting for 10 seconds straight after treatment in 1 patient.

If you want to know more about the studies, see the guidance. Ask your health professional to explain anything you don't understand.

  • Information Standard